首页|期刊导航|国际眼科杂志|木犀草素在眼科疾病中的研究进展

木犀草素在眼科疾病中的研究进展OA

Research progress of luteolin in ocular diseases

中文摘要英文摘要

天然黄酮类化合物因其良好的生物安全性和多重药理活性而受到广泛关注.其中,木犀草素(luteolin)作为代表性成分,在多种眼科疾病模型中显示出显著的抗炎、抗氧化、抗血管生成及神经保护作用.其作用机制主要涉及NF-κB、PI3K/Akt、Nrf2/HO-1、AGE-RAGE等关键信号通路的调控.大量实验研究表明,木犀草素在角膜与眼表疾病、炎症性眼病、青光眼、白内障、糖尿病视网膜病变及年龄相关性黄斑变性等多种疾病的防治中具有潜在应用价值.然而,其临床研究仍有限.文章系统综述了近 5a来木犀草素在眼科疾病中的研究进展,分析其分子机制与治疗潜力,并探讨未来的研究方向,为其临床转化提供理论依据.

Natural flavonoids have attracted considerable attention owing to their favorable biosafety profiles and multiple pharmacological properties in recent years.Luteolin,a representative flavonoid compound,exhibits anti-inflammatory,antioxidant,anti-angiogenic,and neuroprotective effects in multiple ocular disease models by modulating key signaling pathways,including NF-κB,PI3K/Akt,Nrf2/HO-1,and AGE-RAGE.Accumulating experimental evidence supports the potential application of luteolin in various ocular diseases,including corneal and ocular surface diseases,inflammatory eye diseases,glaucoma,cataract,diabetic retinopathy,and age-related macular degeneration.However,clinical evidence remains limited.This review systematically summarizes research progress on luteolin in ocular diseases over the past five years,analyzes its molecular mechanisms and therapeutic potential,and discusses future directions,so as toprovide a theoretical basis for clinical translation.

贺思捷;郭滨;蒋文君

(250014)中国山东省济南市,山东中医药大学(250014)中国山东省济南市,山东中医药大学||(250002)中国山东省济南市,山东中医药大学附属眼科医院山东省中西医结合眼病防治重点实验室 山东省眼病防治研究院 山东省眼视光与青少年视力低下防控临床医学研究中心(250002)中国山东省济南市,山东中医药大学附属眼科医院山东省中西医结合眼病防治重点实验室 山东省眼病防治研究院 山东省眼视光与青少年视力低下防控临床医学研究中心

木犀草素眼科疾病抗氧化抗炎

luteolinocular diseasesantioxidationanti-inflammation

《国际眼科杂志》 2026 (4)

651-656,6

山东省自然科学基金项目(No.ZR2020MH393)山东中医药大学临床科研专项(No.LCKY202432) Natural Science Foundation of Shandong Province(No.ZR2020MH393)Clinical Research Special Project of Shandong University of Traditional Chinese Medicine(No.LCKY202432)

10.3980/j.issn.1672-5123.2026.4.17

评论